(Q50971788)

English

Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects.

scientific article published in March 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

dexamethasone suppression test

0 references

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

O'Sullivan BT

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

Cutler DJ

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

Hunt GE

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

Walters C

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

Johnson GF

5

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

Caterson ID

6

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

language of work or name

0 references

publication date

1 March 1997

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

41

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

5

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

574-584

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Association between low plasma levels of dexamethasone and elevated levels of cortisol in psychiatric patients given dexamethasone.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Plasma dexamethasone concentrations and cortisol suppression response in patients with endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

The Carroll rating scale for depression. I. Development, reliability and validation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Bioavailability of oral dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

A diagnostic interview: the schedule for affective disorders and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

A radioimmunoassay procedure for dexamethasone: plasma and urine levels in man

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Clinical correlates of response to DST. The Dexamethasone Suppression test in depression: a World Health Organisation collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Modeling the pharmacokinetics and pharmacodynamics of dexamethasone in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Shortened dexamethasone half-life in depressed dexamethasone nonsuppressors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

The plasma dexamethasone variable in depression: test-retest studies and early biophase kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Effect of high plasma dexamethasone levels on DST sensitivity: dose-response study in depressed patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

The plasma dexamethasone "window" and the dexamethasone suppression test in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Plasma dexamethasone and the dexamethasone suppression test. Initial and follow-up tests in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Differences in metabolic properties among cortisol, prednisolone, and dexamethasone in liver and renal diseases: accelerated metabolism of dexamethasone in renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Dose-dependent pharmacokinetics of dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Dexamethasone bioavailability: implications for DST research

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Dexamethasone kinetics in depressed patients before and after clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Dexamethasone concentrations and the dexamethasone suppression test in psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

The DST as a predictor of outcome in depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Plasma dexamethasone concentrations and the dexamethasone suppression test

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Disrupted 24-hour Patterns of Cortisol Secretion in Psychotic Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Plasma dexamethasone kinetics during the DST after oral and intravenous administration of the test drug

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

The dexamethasone suppression test in healthy controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900094-7

7 January 2021

Identifiers

10.1016/S0006-3223(96)00094-7

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9046990

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50971788&oldid=2143556367"